2023 Clinical Pharmacology Organic Chemistry Research 
Drug Target Review
JULY 4, 2023
Patient advocacy groups, such as Friends of Cancer Research, are also encouraging regulators to ensure drug developers in the oncology space invest in the optimisation of dosing regimens to help better balance efficacy and safety and thereby deliver more effective patient outcomes. 2022 Nov 14 [cited 2023 Apr 6];40(11):1255–63.
Drug Discovery World
NOVEMBER 8, 2023
On Day 1, Tuesday 14 November 2023, the tracks include: Display of biologics, antibody-based cancer therapies, safety and efficacy of bispecific antibodies, modulating the tumour microenvironment, optimisation and developability, and cell line and systems engineering. from engineered peptide and antibody libraries’.
Expert insights. Personalized for you.
145 
Let's personalize your content